EL DORADO HILLS, Calif.--(BUSINESS WIRE)--April 19, 2005--PhereSys Therapeutics Corporation announced today the opening of its Northeast regional office in the New York City metropolitan area as part of its continuing commitment to build the nation’s most comprehensive, contract mobile Therapeutic Apheresis (“TA”) network. “The opening of the New York office is a key component of PhereSys’ aggressive growth strategy to establish a nationwide footprint,” said Richard Davis, MD, Chairman, President and Chief Executive Officer of PhereSys Therapeutics. “The New York metropolitan area, combined with our existing operations in Southern California, provides access to a total population exceeding 30 million people.”
